An Interview With John MacMahon, CEO of CytoKind, on the Benefits of Artificial Sunlight
About this episode
Larry Luxner interviews John MacMahon about the benefits of artificial sunlight and its application in treating fatigue for multiple sclerosis patients.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews John MacMahon, a New Hampshire-based medical devices company that specializes in phototherapy to treat fatigue in people with multiple sclerosis.
More episodes of Rare Care Podcast
- An Interview WIth Diane Zipursky Quale of the Bladder Cancer Advocacy Network
- An Interview With AI Expert Dr. Laurah Turner on Artificial Intelligence in Medical Education
- An Interview With Dr. Eric Small, Former President of ASCO
- An Interview With Jessie Dubief, Social Research Director at Eurordis, on Mental Health in Rare Diseases
- An Interview With Naomi Aziz, Patient Advocacy and Engagement Lead at the Endometrial Cancer Research Foundation
- An Interview With Naomi Aziz, Patient Advocacy and Engagement Lead at the Endometrial Cancer Research Foundation
Explore listener stats, chart rankings, contacts and more on the Rare Care Podcast podcast page.